Clinuvel Pharmaceuticals Limited (CUV.AX)
AUD 10.76
(0.19%)
AUD 10.76
(0.19%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 10.62 Million AUD | 11.63% |
| 2023 | 9.51 Million AUD | 419.65% |
| 2022 | 1.83 Million AUD | -42.51% |
| 2021 | 3.18 Million AUD | 147.43% |
| 2020 | 1.28 Million AUD | -39.71% |
| 2019 | 2.13 Million AUD | 233.09% |
| 2018 | 641.28 Thousand AUD | -48.35% |
| 2017 | 1.24 Million AUD | 14.73% |
| 2016 | 1.08 Million AUD | 29.27% |
| 2015 | 837.13 Thousand AUD | 0.0% |
| 2014 | - AUD | -100.0% |
| 2013 | 1.00 AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | -100.0% |
| 2006 | 579.91 Thousand AUD | 1719.46% |
| 2005 | 31.87 Thousand AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | -100.0% |
| 2002 | 93.00 AUD | 114.46% |
| 2001 | -643.00 AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 12.55 Million AUD | 0.0% |
| 2024 Q4 | 10.62 Million AUD | 0.0% |
| 2024 FY | 10.62 Million AUD | 11.63% |
| 2023 FY | 9.51 Million AUD | 419.65% |
| 2023 Q2 | 4.46 Million AUD | 0.0% |
| 2023 Q4 | 9.51 Million AUD | 0.0% |
| 2022 FY | 1.83 Million AUD | -42.51% |
| 2022 Q4 | 1.83 Million AUD | 0.0% |
| 2022 Q2 | 3.14 Million AUD | 0.0% |
| 2021 Q4 | 3.18 Million AUD | 0.0% |
| 2021 FY | 3.18 Million AUD | 147.43% |
| 2021 Q2 | 1.31 Million AUD | 0.0% |
| 2020 Q4 | 1.28 Million AUD | 0.0% |
| 2020 Q2 | 1.91 Million AUD | 0.0% |
| 2020 FY | 1.28 Million AUD | -39.71% |
| 2019 FY | 2.13 Million AUD | 233.09% |
| 2019 Q2 | 446.49 Thousand AUD | 0.0% |
| 2019 Q4 | 2.13 Million AUD | 0.0% |
| 2018 FY | 641.28 Thousand AUD | -48.35% |
| 2018 Q4 | 641.28 Thousand AUD | 0.0% |
| 2018 Q2 | 1.08 Million AUD | 0.0% |
| 2017 Q4 | 1.24 Million AUD | 0.0% |
| 2017 Q2 | 1.35 Million AUD | 0.0% |
| 2017 FY | 1.24 Million AUD | 14.73% |
| 2016 Q4 | 1.08 Million AUD | 0.0% |
| 2016 FY | 1.08 Million AUD | 29.27% |
| 2016 Q2 | 1.35 Million AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | 837.13 Thousand AUD | 0.0% |
| 2015 Q4 | 837.13 Thousand AUD | 0.0% |
| 2014 FY | - AUD | -100.0% |
| 2014 Q2 | 1.00 AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2013 Q4 | 1.00 AUD | 0.0% |
| 2013 FY | 1.00 AUD | 0.0% |
| 2013 Q3 | - AUD | -100.0% |
| 2013 Q2 | 1.00 AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | -100.0% |
| 2006 FY | 579.91 Thousand AUD | 1719.46% |
| 2006 Q4 | 579.91 Thousand AUD | 0.0% |
| 2005 FY | 31.87 Thousand AUD | 0.0% |
| 2005 Q4 | 31.87 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | -100.0% |
| 2002 FY | 93.00 AUD | 114.46% |
| 2002 Q4 | - AUD | 0.0% |
| 2001 FY | -643.00 AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | 732.717% |
| Acrux Limited | 147 Thousand AUD | -7128.988% |
| Race Oncology Limited | 16.4 Thousand AUD | -64692.47% |
| Biome Australia Limited | 1.88 Million AUD | -462.678% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | -778.687% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 8.93 Billion AUD | 99.881% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | -658.396% |
| Hexima Limited | - AUD | -Infinity% |
| Immutep Limited | 2.00 AUD | -531330550.0% |
| Memphasys Limited | 164.76 Thousand AUD | -6349.714% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 550.425% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 1176.208% |
| Starpharma Holdings Limited | 2.4 Million AUD | -341.305% |
| Tissue Repair Ltd | 214.72 Thousand AUD | -4849.01% |
| Biotron Limited | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 1.00 AUD | -1062661200.0% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 1683.481% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 1.25 Million AUD | -748.56% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | -803.134% |
| Imugene Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | -17.99 Million AUD | 159.05% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | -9720.906% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Nanollose Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 11287.91% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 1311.369% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 38.61% |
| Dimerix Limited | - AUD | -Infinity% |
| PharmAust Limited | - AUD | -Infinity% |
| AnteoTech Limited | 221.85 Thousand AUD | -4689.848% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -10842.073% |
| Actinogen Medical Limited | 108.82 Thousand AUD | -9664.505% |
| Immuron Limited | 1.58 Million AUD | -570.615% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |